Salivary Secretory Carcinoma

Identification of secretory carcinoma of the salivary gland; a review of pathological characteristics and follow up testing.

Speaker: Dr. Martin Hyrcza, FRCPC, MD/PhD, MSc, BSc, Molecular biologist and an anatomical pathologist, Foothills Medical Center and Rockyview General Hospital.

Thursday, Nov 5, 2020 1400-1500 EST

Register Here

At the end of the session, participants will be able to:

  • Review the pathology of secretory carcinoma
  • Review the natural history of secretory carcinoma
  • Review the diagnostic and predictive molecular testing.

Host: Anna Plotkin, OAP President

Target audience: Pathologists, Resident, Medical Student, Pathologists’ Assistants

CanMEDS Role: Medical Expert, Communicator, Collaborator, Leader, Professional


This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the CAP-ACP. You may claim a maximum of 1.0 hours per event attended. (credits are automatically calculated).

This webinar is co-developed with Bayer and OAP was planned to achieve scientific integrity, objectivity and balance.

The physician organization (OAP) has ultimate authority over all decisions and is accountable to ensure that the administrative, educational and ethical accreditation standards for group learning activities are met.

 


Meet the Speaker

Dr Hyrcza is a molecular biologist and an anatomical pathologist. He completed the MD/PhD program at the University of Toronto with the PhD thesis focusing on the transcriptional regulation of the type I interferon responses in HIV infection. He then completed anatomical pathology training at the University of British Columbia and a fellowship in Head & Neck and Endocrine Pathology at UofT. He is currently the consultant pathologist in Head and Neck, Ophthalmic & Endocrine Pathology at the Foothills Medical Center and Rockyview General Hospital.